Surgical Navigation Systems – Market Insights – United States
While the COVID-19 pandemic has significantly impacted the US surgical navigation system market as regional restrictions on elective procedures resulted in delays to elective procedures and declining unit sales, long-term growth will continue to be driven by demand for better patient outcomes, favorable results of clinical trials and declining cost of navigation systems, which will drive the uptake of novel technologies in navigation-assisted surgeries As a result, the surgical navigation system market as a whole will grow moderately over the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for surgical navigation systems in the US across a 11-year period.
The COVID-19 pandemic has significantly impacted procedures that utilize surgical navigation
How were procedure volumes in different segments of the market affected by the pandemic?
How will recovery vary by segment?
How are competitors preparing for the recovery of deferred procedures?
The underpenetrated US market for surgical navigation systems will grow due to declining system costs, better clinical awareness, and improving technology.
How will the adoption and use of surgical navigation systems differ between neurosurgery, spine, and orthopedic procedures?
To what degree will these factors impact the growth in navigated procedural volumes?
New entrants to the market are bringing easy-to-use, low-cost alternatives that some surgeons prefer over more traditional systems.
What unmet surgeon needs can new entrants to the US surgical navigation market cater to?
What perceptions of this technology exist and what factors affect adoption of these products?
How are new entrants faring in competition against established players?
Facilities looking to increase cost-effectiveness and avoid high readmission rates will be attracted to the precision of navigation systems.
Will health care reform legislation hinder or help the adoption of surgical navigation equipment in the US?
How will limited reimbursement for navigation procedures limit the growth of this market?
Table of contents
- Surgical Navigation Systems - Market Insights - United States
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- COVID-19 Analysis
- Surgical Navigation System Market
- Neurosurgery Navigation System Market
- Spine Navigation System Market
- ENT Navigation System Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR Disclaimer
- ENT Procedures, by Anatomy, US, 2019u20132030
- Ear Procedures, by Procedure Type, US, 2019u20132030
- Nose and Sinus Procedures, by Procedure Type, US, 2019u20132030
- FESS, by Technique, US, 2019u20132030
- Balloon Sinus Dilation, by Procedure Type, US, 2019u20132030
- Hybrid Balloon Sinus Dilation, by Technique, US, 2019u20132030
- Stand-Alone Balloon Sinus Dilation, by Technique, US, 2019u20132030
- Throat Procedures, by Procedure Type, US, 2019u20132030
- ENT Navigation Systems Sold and Installed Base, US, 2019u20132030
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Orthopedic Navigation System Market
- Appendix
Sumit Jain is a senior team lead within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Clarivate, focusing on diagnostic imaging capital equipment and healthcare IT markets. Sumit holds a Bachelor’s degree in Pharmacy from the Rajiv Gandhi Technical University, Bhopal, and a Master’s degree in Pharmacoinformatics from the National Institute of Pharmaceutical Education and Research, Mohali.